1. Collins, AJ, Foley, RN, Gilbertson, DT, et al. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl 2015; 5(1): 2–7.
Google Scholar | Crossref2. GBD Chronic Kidney Disease Collaboration . Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020; 395(10225): 709–733.
Google Scholar | Crossref | Medline3. Koye, DN, Magliano, DJ, Nelson, RG, et al. The global epidemiology of diabetes and kidney disease. Adv Chronic Kidney Dis 2018; 25(2): 121–132.
Google Scholar | Crossref | Medline4. Shen, Y, Cai, R, Sun, J, et al. Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis. Endocrine 2017; 55(1): 66–76.
Google Scholar | Crossref | Medline5. Li, PK, Cheung, WL, Lui, SL, et al. Increasing home-based dialysis therapies to tackle dialysis burden around the world: a position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis. Hemodial Int 2011; 15(1): 10–14.
Google Scholar | Crossref | Medline6. Jain, AK, Blake, P, Cordy, P, et al. Global trends in rates of peritoneal dialysis. J Am Soc Nephrol 2012; 23(3): 533–544.
Google Scholar | Crossref | Medline7. Blake, PG, Brown, EA. Person-centered peritoneal dialysis prescription and the role of shared decision-making. Perit Dial Int 2020; 40(3): 302–309.
Google Scholar | SAGE Journals8. Gokal, R, Moberly, J, Lindholm, B, et al. Metabolic and laboratory effects of icodextrin. Kidney Int Suppl 2002; (81): S62–S71.
Google Scholar | Crossref | Medline9. Li, PK, Culleton, BF, Ariza, A, et al. Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol 2013; 24(11): 1889–1900.
Google Scholar | Crossref | Medline10. Holmes, CJ, Shockley, TR. Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int 2000; 20(suppl 2): S37–S41.
Google Scholar | SAGE Journals11. Nolph, KD, Rosenfeld, PS, Powell, JT, et al. Peritoneal glucose transport and hyperglycemia during peritoneal dialysis. Am J Med Sci 1970; 259(4): 272–281.
Google Scholar | Crossref | Medline12. Davies, SJ . Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 2004; 66(6): 2437–2445.
Google Scholar | Crossref | Medline13. Ha, H, Lee, HB. Effect of high glucose on peritoneal mesothelial cell biology. Perit Dial Int 2000; 20(suppl 2): S15–S18.
Google Scholar | SAGE Journals14. Krediet, RT . Ultrafiltration failure is a reflection of peritoneal alterations in patients treated with peritoneal dialysis. Front Physiol 2018; 9: 1815.
Google Scholar | Crossref | Medline15. Churchill, DN, Thorpe, KE, Nolph, KD, et al. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9(7): 1285–1292.
Google Scholar | Crossref | Medline16. Williams, JD, Craig, KJ, Topley, N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease J Am Soc Nephrol. 2002; 13(2): 470–479.
Google Scholar | Crossref | Medline17. Xue, C, Gu, YY, Cui, CJ, et al. New-onset glucose disorders in peritoneal dialysis patients: a meta-analysis and systematic review. Nephrol Dial Transplant 2020; 35(8): 1412–1419.
Google Scholar | Crossref | Medline18. Szeto, CC, Chow, KM, Kwan, BC, et al. New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis. Am J Kidney Dis 2007; 49(4): 524–532.
Google Scholar | Crossref | Medline19. Öberg, CM, Rippe, B. Optimizing automated peritoneal dialysis using an extended 3-pore model. Kidney Int Rep 2017; 2(5): 943–951.
Google Scholar | Crossref | Medline20. Bergling, K, de Arteaga, J, Ledesma, F, et al. Optimized vs. Standard Automated Peritoneal Dialysis Regimens (OptiStAR): study protocol for a randomized controlled crossover trial. Pilot Feasibility Stud 2020; 6: 81.
Google Scholar | Crossref | Medline21. Martus, G, Bergling, K, Simonsen, O, et al. Novel method for osmotic conductance to glucose in peritoneal dialysis. Kidney Int Rep 2020; 5(11): 1974–1981.
Google Scholar | Crossref | Medline22. Öberg, CM . Optimization of bimodal automated peritoneal dialysis prescription using the three-pore model. Perit Dial Int 2021; 41(4): 381–393.
Google Scholar | SAGE Journals23. Demetriou, D, Habicht, A, Schillinger, M, et al. Adequacy of automated peritoneal dialysis with and without manual daytime exchange: a randomized controlled trial. Kidney Int 2006; 70(9): 1649–1655.
Google Scholar | Crossref | Medline24. Waniewski, J, Stachowska-Pietka, J, Lindholm, B. On the change of transport parameters with dwell time during peritoneal dialysis. Perit Dial Int 2021; 41(4): 404–412.
Google Scholar | SAGE Journals25. Abensur, H, Romao Junior, JE, Prado, EB, et al. Influence of the hydrostatic intraperitoneal pressure and the cardiac function on the lymphatic absorption rate of the peritoneal cavity in CAPD. Adv Perit Dial 1993; 9: 41–45.
Google Scholar | Medline26. Jotterand Drepper, V, Kihm, LP, Kälble, F, et al. Overhydration is a strong predictor of mortality in peritoneal dialysis patients – independently of cardiac failure. PLoS One 2016; 11(7): e0158741.
Google Scholar | Crossref | Medline27. Yoon, HE, Kwon, YJ, Song, HC, et al. Overhydration negatively affects quality of life in peritoneal dialysis patients: evidence from a prospective observational Study. Int J Med Sci 2016; 13(9): 686–695.
Google Scholar | Crossref | Medline28. Heimbürger, O, Waniewski, J, Werynski, A, et al. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992; 41(5): 1320–1332.
Google Scholar | Crossref | Medline